ORACEA: payments to doctors
Payments that named ORACEA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.4M
- Providers
- 7,638
- Transactions
- 35,676
- Average per transaction
- $95
The per-transaction average — $95 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,638 providers the average total is $445, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Galderma Laboratories, L.p. | $3,327,622 | 97.8% |
| Galderma International SAS | $74,078 | 2.2% |